TEL: (+62) 21 5890 1590
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
When it comes to skin concerns, uneven texture is top of mind for many aesthetics patients. Among the top skin tone and texture issues treated, rosacea, bumps, acne scars, and stretch marks are some of the most common, alongside uneven pigmentation. In fact, one survey from the American Society for Dermatologic Surgery (ASDS) reports that 71% of aesthetic patients are concerned with skin tone and texture. Unfortunately, conditions like these can be tough to treat.
Skin resurfacing treatments are currently the best tools available to medical aesthetics practitioners for treating these common tone and texture issues; however, not all treatments are created equally. Results can vary quite a bit between devices, protocols, and other factors, such as a patient not wearing sunscreen. However, one factor that remains the same across skin resurfacing treatments and patients is a concern for post-inflammatory hyperpigmentation (PIH).
Post-inflammatory hyperpigmentation (PIH) results from an overproduction or uneven disbursement of melanin in the skin as a natural reaction to injury and defense against inflammation. PIH presents as flat, discolored spots on the skin, resulting in an uneven skin tone. While there is no medical concern associated with PIH, it certainly contributes to the demand for skin resurfacing solutions to treat patients’ skin tone and texture concerns.
For many, inflammation that may prompt PIH is most often due to acne vulgaris (pimples), atopic dermatitis (eczema/rash), and impetigo (bacterial infection). UV exposure, insect bites, allergic reactions, chronic diseases like psoriasis, or side effects from certain medications may also increase one’s risk of PIH, as well as some medical aesthetic procedures if not done correctly.
PIH can certainly occur in all skin types and tones, but those with darker skin tones are most at risk. More specifically, the Journal of Clinical and Aesthetic Dermatology reports that those with Fitzpatrick skin types IV to VI—which actually comprises a significant portion of the global aesthetic market, as this includes most Latin Americans, Asians, Pacific Islanders, people of African descent, people of Middle Eastern descent, and the Indigenous peoples of North America—are at highest risk of experiencing PIH. Unfortunately, there are few skin resurfacing treatments that are safe for patients with these skin types, meaning your clinic could lose out on a large number of prospective patients—but only if you’re unprepared.
Since PIH causes an uneven skin tone, it’s one of the many reasons people seek skin resurfacing treatments. It’s important to note, though, that some treatments cause additional inflammation and worsening of the condition—especially in darker skin tones. There are safer skin resurfacing treatments for these patients, though.
For clinics committed to offering advanced aesthetic treatments to a more diverse patient base and building out a strong patient referral program, choosing the right device can make a world of difference. Get started on the right track with our comprehensive report, PIH and Cosmetic Procedures: Safe Skin Resurfacing Options for Patients Concerned about PIH, that covers the risks associated with PIH and skin resurfacing treatments, as well as the top advances in medical aesthetic technology that can help you deliver outstanding results to your prospective patients. Simply click the Download Now button below to access the report today!
For more information call: (+62 21) 5890 1590 // info.id@venusconcept.com // Ruko Business Park Kebon Jeruk Blok B11 Jl. Meruya Ilir Raya No. 88 Kel. Meruya Utara, Kec. Kembangan West Jakarta 11620
REGULATORY CLEARANCES [ More ]
All devices have received Indonesian Health Ministry Approval for sale and use in Indonesia. (Izin Edar Alat Kesehatan)
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Viva™ is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for the treatment of moderate to severe wrinkles and rhytides in Fitzpatrick skin types I-IV.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of stretch marks at the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Copyright © 2018 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click Here